1013 Assessing HIV treatment related worries and stigma: Psychometric properties of a novel, brief patient-reported outcome measure Irina Kolobova 1 , Tamra Keeney 2 , Christina Donatti 3 , Amara Orji 2 , Lauren Henning 2 , Dominy Browning 3 , Mark Kosinski 2 1 ViiV Healthcare, Durham, North Carolina, USA, 2 IQVIA Quality Metric, Inc., Providence, Rhode Island, USA, 3 ViiV Healthcare, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1013 Aims Many people with HIV (PWH) experience heightened emotional burden and challenges related to daily oral medication regimens, which impact well-being and treatment adherence
Aamann L, Dam G, Borre M, Drljevic-Nielsen A, Overgaard K, Andersen H, et al
A glucagon-like Peptide-1 receptor agonist lowers weight by modulating the structure of gut microbiota
Shop Medications , The choice between a GLP-1 pill and injection isnt just about personal preference
These can include: Patients should seek urgent medical advice if they develop severe abdominal pain, persistent vomiting, signs of dehydration, yellowing of the skin or eyes, swelling of the face or throat, or difficulty breathing
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV
